INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

555 studies · page 10 of 24

2022 / Statistical report / narrative review

The American Heart Association's 2022 Statistical Update compiles current data on heart disease, stroke, and cardiovascular risk factors.

The American Heart Association and the National Institutes of Health compiled the 2022 Statistical Update on heart disease, stroke, and cardiovascular risk factors. It covers core health behaviors such as diet, smoking, physical activity, and weight, as well as health factors including blood pressure, cholesterol, and glucose control. The 2022 edition adds an enhanced focus on social determinants of health, adverse pregnancy outcomes, vascular contributions to brain health, and the global burden of cardiovascular disease.

Tsao CW, Aday AW, Almarzooq ZI, et al. Circulation, 2022. PMID 35078371

2022 / Narrative review

Piperine displays pleiotropic pharmacological properties and therapeutic benefits across various diseases according to clinical and preclinical data.

This review summarizes clinical and preclinical evidence regarding the molecular and pharmacological activities of piperine. According to the review, piperine demonstrates antioxidant, anticancer, anti-inflammatory, and antihypertensive properties, and provides therapeutic benefits in conditions including diabetes, obesity, cardiovascular diseases, kidney diseases, and hypertension. These effects are mediated through the modulation of various signaling molecules, enzymes, pathways, and the gut microbiota.

Tripathi AK, Ray AK, Mishra SK Beni Suef Univ J Basic Appl Sci, 2022. PMID 35127957

2022 / Evidence-based dietary guideline

A guideline recommends 400 to 600 mg/d of dietary flavan-3-ols from food to support cardiometabolic health.

An Expert Panel developed a food-based intake recommendation for flavan-3-ols based on a review of 157 randomized controlled trials and 15 cohort studies using the Academy of Nutrition and Dietetics Evidence to Decision Framework. Moderate evidence supported cardiometabolic protection from dietary flavan-3-ol intake in the range of 400-600 mg/d. Increasing dietary intake was found to improve blood pressure, cholesterol levels, and blood sugar, with the strongest evidence for systolic blood pressure, total cholesterol, HDL cholesterol, and insulin/glucose dynamics. This recommendation is food-based and not intended for supplements.

Crowe-White KM, Evans LW, Kuhnle GGC, et al. Adv Nutr, 2022. PMID 36190328

2021 / Narrative review

A review indicates that no specific diet fully meets iodine requirements, meaning iodine supplementation remains necessary.

Iodine deficiency affects approximately 2 billion people worldwide, with pregnant women identified as a high-risk group. While global salt iodization programs eradicated endemic goitre, recommendations to reduce salt intake to prevent hypertension and cancer pose challenges to iodine adequacy. Despite sources like fish, seafood, dairy, water, and vegetables, diets high in unionized salt from processed foods, alternative diets, or restricted salt intake can lead to deficiency. The review concludes that no diet appears to fully cover iodine requirements without food supplementation.

Krela-Kaźmierczak I, Czarnywojtek A, Skoracka K, et al. Nutrients, 2021. PMID 33557336

2021 / Literature review

A review found that dietary toxins, metals, well water, and hypertension were linked to higher progressive supranuclear palsy risk.

This review examined literature evaluating the relationship between progressive supranuclear palsy (PSP) and environmental and modifiable lifestyle risk factors. Exposures to toxins related to diet, metals, well water, and hypertension were associated with increased PSP risk, while higher education and statins may be protective. The authors note that further case-control studies are needed to determine the exact role of these factors in PSP etiopathogenesis.

Shows an association, not proof of cause and effect.

Park HK, Ilango SD, Litvan I J Mov Disord, 2021. PMID 34062646

2020 / Narrative review

Plant-based diets may aid in the primary and secondary prevention of chronic kidney disease without supported risks of hyperkalemia or protein inadequacy.

This review examines the role of plant-based diets in the prevention and management of chronic kidney disease (CKD). Observational studies indicate red and processed meat are associated with increased CKD risk and faster progression, while substituting one serving of these meats was linked to sizable risk reductions. Limited experimental trials show treating metabolic acidosis in CKD with fruits and vegetables yields outcomes comparable to oral bicarbonate. The authors report that concerns regarding potassium overload and protein inadequacy from plant-based diets appear overstated and lack evidence-based support.

Joshi S, Hashmi S, Shah S, et al. Curr Opin Nephrol Hypertens, 2020. PMID 31725014

2020 / Narrative review

Potassium-enriched salt substitutes lower systolic and diastolic blood pressure, but evidence on hyperkalemia risk remains insufficient.

This review evaluated the benefits and risks of replacing sodium chloride with potassium-enriched salt substitutes. Empirical evidence shows that this replacement lowers systolic blood pressure by an average net delta of -5.58 mm Hg (95% CI: -7.08 to -4.09) and diastolic blood pressure by -2.88 mm Hg (95% CI: -3.93 to -1.83). Potential risks include hyperkalemia, arrhythmias, and sudden cardiac death, especially in individuals with impaired potassium excretion such as chronic kidney disease. However, the authors note there is currently insufficient evidence regarding the effects of these substitutes on the occurrence of hyperkalemia.

Greer RC, Marklund M, Anderson CAM, et al. Hypertension, 2020. PMID 31838902

2020 / Narrative review of observational studies and randomized trials

Whole-apple intake is linked to lower cardiovascular disease risk and improves multiple cardiovascular risk factors.

This narrative review evaluated evidence from 8 observational studies and 8 randomized trials on whole-apple intake and cardiovascular disease risk factors. In the observational studies, apple intake was linked to lower CVD mortality, ischemic heart disease mortality, stroke mortality, all-cause mortality, severe abdominal aortic calcification, and lower C-reactive protein. In randomized trials, consuming whole apples reduced total cholesterol, LDL cholesterol, systolic blood pressure, pulse pressure, inflammatory cytokines, and CRP, while increasing HDL cholesterol and improving endothelial function. The review concluded that consuming 100 to 150 g/day of whole apples associates with lower CVD risk and benefits various risk markers.

Sandoval-Ramírez BA, Catalán Ú, Calderón-Pérez L, et al. Crit Rev Food Sci Nutr, 2020. PMID 31928209

2020 / Annual statistical report

The American Heart Association's 2020 report compiles current statistics on heart disease, stroke, and cardiovascular risk factors.

The American Heart Association, together with the National Institutes of Health, annually updates statistics on heart disease, stroke, and cardiovascular risk factors including diet, physical activity, smoking, and weight. The 2020 update spans 26 chapters covering major circulatory conditions, outcomes, economic costs, social determinants of health, and the global burden of cardiovascular disease. It provides metrics to assess and monitor healthy diets and behaviors related to the AHA 2020 Impact Goals.

Virani SS, Alonso A, Benjamin EJ, et al. Circulation, 2020. PMID 31992061

2020 / Review of randomized controlled trials

Dietary interventions including antioxidants and hypocaloric diets improve antioxidant status and reduce oxidative stress in metabolic diseases.

This review evaluated randomized controlled intervention studies published in MEDLINE over a 5-year period examining dietary interventions and oxidative stress markers in subjects with obesity, hypertension, diabetes, or dyslipidemia. The review found that food antioxidants, hypocaloric diets with loss of adipose tissue, substitution of animal protein with vegetable protein, and changes in the microbiota improve antioxidant status in people with chronic metabolic conditions. Consumption of foods high in antioxidants and polyphenols increases plasma antioxidant capacity and lowers oxidative stress markers in these populations.

Ávila-Escalante ML, Coop-Gamas F, Cervantes-Rodríguez M, et al. J Food Biochem, 2020. PMID 32160647

2020 / Narrative review

A review examined the therapeutic potential, mechanisms, efficacy, and safety of four medicinal plants in cardiovascular disease management.

This review evaluates the ethnopharmacological therapeutic potential, mechanisms, efficacy, and safety of Ginseng, Ginkgo biloba, Ganoderma lucidum, and Gynostemma pentaphyllum for cardiovascular diseases. It synthesizes findings from in vitro, in vivo, and clinical trial studies covering conditions such as hypertension, coronary heart disease, myocardial infarction, cardiomyopathies, peripheral vascular diseases, and dyslipidemias. The authors emphasize that while these herbs demonstrate therapeutic promise against CVD risk factors, their claimed safety requires proper testing due to potential toxicity, adverse effects, and herb-drug interactions.

Shaito A, Thuan DTB, Phu HT, et al. Front Pharmacol, 2020. PMID 32317975

2020 / Narrative review

A review indicates high sodium intake is directly related to increased blood pressure, target organ damage, and elevated cardiovascular risk.

This review examines evidence on sodium intake and target organ damage in hypertension. The authors report that current global sodium consumption exceeds safe levels and that sodium intake is directly related to increased blood pressure and independently to cardiac mass enlargement. High sodium intake may also induce renal damage progression in both hypertensive and normotensive individuals and play an adverse role in cerebrovascular disease.

Nista F, Gatto F, Albertelli M, et al. Int J Environ Res Public Health, 2020. PMID 32325839

2020 / Narrative review

A review notes lifestyle modifications like low sodium diet and weight loss can help control hypertension in African Americans.

This review examined literature from PubMed, guideline reports, and newer publications regarding hypertension and COVID-19 in African Americans. It highlights that the increased prevalence and risks of hypertension are primarily due to environmental and lifestyle factors, such as poor diet and adverse social determinants. Blood pressure control can be supported through lifestyle changes, including a low-sodium diet, weight loss, and physical activity, alongside pharmacological or novel treatments when needed. Additionally, existing comorbidities like hypertension and obesity contribute to worse COVID-19 outcomes in this population.

Ferdinand K, Batieste T, Fleurestil M J Natl Med Assoc, 2020. PMID 32563685

2020 / Review of a population-based lifestyle intervention project

The North Karelia Project's community lifestyle interventions were followed by major reductions in CVD risk factors and mortality in Finland.

Initiated in 1972 in response to high cardiovascular mortality among men in North Karelia, the project targeted lifestyle changes through community-based interventions and national policy changes. Dietary recommendations emphasized reducing saturated fat and decreasing salt intake, alongside smoking reduction targets. Following the interventions, which expanded across Finland, significant reductions were observed in serum cholesterol levels, hypertension, smoking prevalence, and cardiovascular disease mortality.

Puska P, Jaini P Am J Lifestyle Med, 2020. PMID 32922234

2019 / Narrative review

Increasing potassium intake lowers blood pressure, especially in hypertensive individuals, and reduces stroke risk by about 25%.

This review evaluates evidence on potassium intake for blood pressure control in essential hypertension and its safety in chronic kidney disease. Over 40 years of evidence demonstrates that increasing potassium intake through foods or supplements is associated with significant reductions in systolic and diastolic blood pressure, particularly in hypertensive patients and those with high sodium intake. Meta-analyses confirm high potassium intake reduces stroke risk by ~25%, and post hoc analyses suggest it may slow renal decline in early CKD. However, high potassium intake may be risky in hypertensive patients with CKD stages 3-5, specifically diabetics, though more prospective studies are needed.

Burnier M Nephrol Dial Transplant, 2019. PMID 29301002

2019 / Narrative review

A review suggests plant-based diets may offer cardiovascular safety and performance advantages for endurance athletes.

This review examined the role of plant-based diets in addressing cardiovascular risks and performance in endurance athletes, who studies suggest face higher-than-average risk for atherosclerosis and myocardial damage. The effect of plant-based diets on risk factors such as plasma lipids, body weight, blood pressure, and reversing existing atherosclerotic lesions may provide substantial cardiovascular protection. Furthermore, plant-based diets have consistently been shown to reduce body fat and indicators of inflammation, foster glycogen storage, and help reduce oxidative stress. By reducing blood viscosity and improving arterial flexibility and endothelial function, they may be expected to improve vascular flow and tissue oxygenation.

Barnard ND, Goldman DM, Loomis JF, et al. Nutrients, 2019. PMID 30634559

2019 / Narrative review of clinical trials

Resveratrol shows therapeutic potential across various diseases in over 244 clinical trials and is reported safe at doses up to 5 g/day.

This review evaluates clinical evidence on the polyphenolic nutraceutical resveratrol, whose efficacy, safety, and pharmacokinetics have been documented in over 244 clinical trials with 27 ongoing. Resveratrol is reported to potentially improve therapeutic outcomes in conditions such as diabetes mellitus, obesity, cancers, metabolic syndrome, hypertension, Alzheimer's disease, cardiovascular diseases, and kidney diseases. It is reported to be safe at doses up to 5 g/day alone or in combination therapy. However, its therapeutic use is limited by rapid metabolism and poor bioavailability, though a micronized formulation (SRT501) shows promise.

Singh AP, Singh R, Verma SS, et al. Med Res Rev, 2019. PMID 30741437

2019 / Narrative review

High dietary salt adversely affects target organs including the heart, kidneys, brain, and bone, irrespective of blood pressure.

This review evaluates the blood pressure-independent physiological effects of dietary salt and controversies surrounding lower salt intakes and cardiovascular outcomes. High dietary salt has been shown to adversely affect the vasculature, heart, kidneys, skin, brain, and bone, mediated commonly by heightened inflammation and oxidative stress. The review also addresses the role of background diet in modulating the effects of salt.

Robinson AT, Edwards DG, Farquhar WB Curr Hypertens Rep, 2019. PMID 31025198

2019 / Updated systematic review of meta-analyses

Nut consumption was linked to lower CVD, CHD, and stroke mortality/incidence, and reduced fasting glucose, total cholesterol, and LDL-C in meta-analyses.

An updated electronic search of PubMed/MEDLINE, CINAHL, and Cochrane Library identified seven new meta-analyses examining nut consumption and cardiometabolic diseases. Comparing high with low consumption categories, nut intake significantly decreased CVD mortality (-19% to -25%; n = 4), CHD mortality (-24% to -30%; n = 3), stroke mortality (-17% to -18%; n = 3), CVD incidence (-15% to -19%; n = 4), CHD/CAD incidence (-17% to -34%; n = 8), and stroke incidence (-10% to -11%; n = 6). Compared with control diets, nut consumption significantly reduced fasting glucose (0.08 to 0.15 mmol/L; n = 6), total cholesterol (0.021 to 0.30 mmol/L; n = 10), and LDL-C (0.017 to 0.26 mmol/L; n = 10). Body weight and blood pressure were not significantly affected.

Shows an association, not proof of cause and effect.

Kim Y, Keogh JB, Clifton PM Int J Environ Res Public Health, 2019. PMID 31817639

2019 / Narrative review

A review suggests that a plant-based diet may serve as a valuable tool for managing atrial fibrillation risk factors.

Atrial fibrillation affects an estimated 34 million individuals globally and carries a significant burden of morbidity and mortality. This review examines evidence regarding the use of a whole-food plant-based diet—emphasizing grains, legumes, vegetables, fruits, and nuts while excluding most or all animal products—for managing atrial fibrillation risk factors. It highlights effects on cardiovascular and metabolic factors including hypertension, coronary artery disease, diabetes, obesity, inflammation, and subclinical atherosclerosis.

Storz MA, Helle P J Arrhythm, 2019. PMID 31844466

2018 / Narrative review

Studies report beneficial cardiovascular effects from dietary flaxseed, including antihypertensive, antiatherogenic, and cholesterol-lowering actions.

This review summarizes reported cardiovascular effects of dietary flaxseed supplementation and its bioactive compounds from preclinical and clinical studies. Reported effects have included an antihypertensive action, antiatherogenic effects, a lowering of cholesterol, an anti-inflammatory action, and an inhibition of arrhythmias. These actions have been primarily implicated with its alpha-linolenic acid, secoisolariciresinol diglucoside, and high fiber content, while other compounds such as proteins, cyclolinopeptides, and cyanogenic glycosides may also produce biological actions.

Parikh M, Netticadan T, Pierce GN Am J Physiol Heart Circ Physiol, 2018. PMID 29101172

2018 / Review of randomized controlled trials and other studies

A review indicates caloric restriction can normalize blood pressure and improve arterial stiffness and heart rate variability.

This review evaluated evidence from randomized controlled trials and other studies on caloric restriction (CR) and cardiovascular parameters. CR was found to significantly improve blood pressure (BP), heart rate variability, arterial stiffness, endothelial dysfunction, and flow-mediated arterial dilatation, allowing patients to discontinue antihypertensive medication without becoming hypotensive. Benefits were seen regardless of age, sex, weight, BMI, or metabolic conditions, with the greatest benefits in the sickest individuals. Exercise enhanced the effects of CR only in hypertensive subjects, while proposed mechanisms include improved insulin sensitivity, increased nitric oxide production, and SIRT1 induction.

Nicoll R, Henein MY Int J Mol Sci, 2018. PMID 29518898

2018 / Narrative review

A review reports that vegetarian dietary patterns reduce CVD mortality and coronary heart disease risk by 40%.

This review examined the relationship between vegetarian dietary patterns and cardiovascular disease (CVD). The authors report that vegetarian diets reduce CVD mortality and coronary heart disease (CHD) risk by 40%, and plant-based diets are the only pattern to have shown CHD reversal. Vegetarian and plant-based diets are also associated with lower blood pressure, lower blood lipids, reduced platelet aggregation, weight management benefits, and reduced risk and effective treatment of type 2 diabetes.

Kahleova H, Levin S, Barnard ND Prog Cardiovasc Dis, 2018. PMID 29800598

2018 / Hypothesis / narrative review

A review hypothesizes that low potassium and excessive sodium intakes promote essential hypertension through oxidative stress-induced vascular dysfunction.

The authors hypothesize that the primary environmental determinant of essential hypertension in Westernized countries is low intake of potassium and phytochemicals paired with supraphysiological sodium intake. This dietary pattern is proposed to cause oxidative stress-induced vascular endothelial and smooth muscle dysfunction, reducing nitric oxide bioavailability and raising vascular resistance. The authors note that Americans currently consume potassium-to-sodium in molar ratios under or near 1.0 (IOM recommends 1.2), compared to ancestral diet estimates of 5.0 to 10.0 or higher.

Sebastian A, Cordain L, Frassetto L, et al. Med Hypotheses, 2018. PMID 30122481